Dame Health Expands Reproductive Nutrition with Male Fertility and Preconception Focus
A fertility and women's reproductive health brand, Dame Health, has rolled out a targeted nutrition portfolio spanning preconception, fertility, PCOS and pregnancy.

For maternal and child health practitioners in India, the launch matters less for the SKUs themselves and more for what it signals: finally placing male-factor nutrition and the three-month preconception window on the same clinical checklist rather than treating them as afterthoughts.
Built Around the Reproductive Lifecycle, Not Generic Wellness
The portfolio is structured around reproductive stages rather than catch-all multivitamins, according to coverage from Newspatrolling.com. Core products include:
- Pre-Pregnancy Support — a women's preconception multivitamin with active folate, iron, choline, NAC, inositol, zinc and B12, positioned for the three months before conception
- Pregnancy Support Plus — a complete prenatal with active folate, ferrous bisglycinate, choline, iodine, zinc, selenium and ginger for all three trimesters
- Men's Fertility Boost — a 21-ingredient daily multivitamin including zinc, active folate, L-arginine, N-acetyl L-carnitine, ashwagandha, shatavari, lycopene, tribulus, selenium, iodine and vitamin D3
- Bio-CoQ10 — a liposomal CoQ10 with vitamins C and E and mucuna pruriens
Adjacent SKUs — Berberine HCL 98% + Milk Thistle for insulin-sensitivity and PCOS support, Plant Protein for Women and Men, Magnesium & Tart Cherry, Dreamy Sleep Gummies and Calcium D3 — extend the line into broader wellness and pregnancy-related needs.
Infrastructure Claims and the Supply Chain Reality
Co-founded by practising fertility specialist and gynaecologist Dr. Rajeev Agarwal and Sahil Agarwal, Dame Health states its products are formulated with clinically studied ingredients and manufactured in GMP-certified, ISO-certified and FSSAI-licensed facilities. From a systems-engineering perspective, those certifications are the load-bearing wall — they determine whether the supply chain can scale without quality drift or batch-to-batch inconsistency.
Dr. Rajeev Agarwal framed the category positioning by noting that the brand treats fertility and pregnancy as a healthcare space where nutrition plays a defined role, rather than as another supplements shelf. Sahil Agarwal pointed to the operational gap his team identified: an abundance of fertility information sitting alongside products that patients cannot realistically parse or integrate into daily routines.
What to Verify Before Integrating Into Clinical Workflow
For practitioners considering this category for preconception counselling, three checkpoints carry real weight:
- Active folate forms — methylated folate rather than folic acid, relevant for the MTHFR-variant population increasingly documented in Indian cohorts
- FSSAI licensing scope — confirm the licence covers the specific SKU and manufacturing site, not just the parent company
- Male-factor inclusion in counselling — any protocol that places men's nutrition on the same appointment checklist as women's closes a gap that has historically skewed preconception care toward one partner
The launch lands at a moment when maternal nutrition infrastructure across India continues to face distribution bottlenecks, particularly in tier-2 and tier-3 city supply lines. The more immediate systems question is whether clinically-positioned preconception supplementation can move from pharmacy shelves into routine antenatal workflows — or whether it stalls at the same retail-pharmacy handoff that has throttled earlier nutrition interventions. Couples asking about these products at the clinic desk deserve a short answer: check the active folate form, verify the FSSAI number against the actual SKU, and put the male partner's regimen on the same printed sheet as the female partner's. That is the minimum viable preconception protocol, brand aside.